Skip to content

PHARMACIE CLABOTS

Active
Private limited company (pre-2019)founded 1993active for 32 yearsRue de Villers-la-Ville 78, 1470 Genappe, BelgiumKBO/BCE: BE 0451.595.376

From the official registers: KBO 32 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

PHARMACIE CLABOTS has been active since 1993 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €433,074 and a net result of -€61,504. Equity is shrinking by about 15% per year across the filed financial years. Its solvency ranks better than 36% of 5,034 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Official details

KBO
Status
Active since 23-12-1993 Normal situation
Legal form
Private limited company (pre-2019)
Registered office
Rue de Villers-la-Ville 78, 1470 Genappe
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.065.111.093 1470 Genappe, since 12-01-1994
Financial year end
31 December
Peppol
Reachable since 22-05-2025

Who decides

Board
Holdings
Shares in 1 company PARA-MARKET

How it is doing

68 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.7%
Annual accounts 2025
Gross margin
€712,343
▲ 11.9%
Turnover
≈ €2.6m
estimated
Loss
€61,504
Equity
€433,074
▼ 12.4%
Total assets
€1.8m
▼ 14.3%
Staff
5.5 FTE
▼ 6.8%
2025 accounts 7 days early
Filed on 24-07-2026at the National Bank
Why 68raises riskSector: Retail trade (NACE 47)Loss of €61,504 (financial year 2025)Equity €433,074 (24.2% of total assets)lowers riskFounded in 1993Show the evidence

Checked score

Score 2025
68 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 32% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 49=
equity 24.2% of total assets
Liquidity 44-4
short-term debt 35.0% · cash 8.0%
Profitability 24-33
return on assets -3.4%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.8%highest value 12-2024: 0.8%● unchanged vs 11-2024highest value 01-2025: 0.8%● unchanged vs 12-2024highest value 02-2025: 0.8%● unchanged vs 01-2025highest value 03-2025: 0.8%● unchanged vs 02-2025highest value 04-2025: 0.4%▼ -0.4 percentage points vs 03-2025lowest value 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.5%▲ +0.1 percentage points vs 05-2025 07-2025: 0.7%▲ +0.2 percentage points vs 06-2025 08-2025: 0.4%▼ -0.3 percentage points vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.5%▲ +0.1 percentage points vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.6%▲ +0.1 percentage points vs 06-2026 08-2026: 0.7%▲ +0.1 percentage points vs 07-2026 09-2026: 0.7%● unchanged vs 08-2026 10-2026: 0.7%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.74, compared with 1.95 in 2024, above the usual 1.5; short-term debt: 35% and cash: 8% of total assets), but 75.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 40% on solvency, 43% on liquidity, 23% on profitability and 24% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Loss of €61,504 (financial year 2025)
NBB · annual accounts
raises risk · Equity €433,074 (24.2% of total assets)
NBB · annual accounts
lowers risk · Founded in 1993
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 days early
2024
17 days early
2023
19 days late
2022
90 days early
2021
75 days early
2020
46 days early
2019
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 34 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (4 of the last 5 filed years within 58 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Caution: From profit to loss in 2025after €30,486 in 2024 -€61,504 View
  • Caution: Among the weakest 15% on net resultsector median €39,952 · 5,033 companies -€61,504 View
  • Controlled by C.V.H.the company in turn controls 1 companies 100% View

Documents

Annual accounts at the NBB

All 32 annual accounts

Articles and registers

Key facts about PHARMACIE CLABOTS

What is the company number of PHARMACIE CLABOTS?
0451.595.376. In Belgium the VAT number is the company number with BE in front: BE 0451.595.376.
Where is PHARMACIE CLABOTS based?
The registered office is at Rue de Villers-la-Ville 78, 1470 Genappe.Company details
What does PHARMACIE CLABOTS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE CLABOTS?
Private limited company (pre-2019) (BVBA).
When was PHARMACIE CLABOTS founded?
On 23-12-1993.
Is PHARMACIE CLABOTS still active?
Yes, PHARMACIE CLABOTS is an active enterprise in the KBO register.
How many employees does PHARMACIE CLABOTS have?
On average 5.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE CLABOTS?
≈ €2.6m in financial year 2025. Estimated from the gross margin of €712,343: probably between €2.0m and €4.3m, based on 47 comparable companies, NACE 477.
Is PHARMACIE CLABOTS profitable?
In financial year 2025, PHARMACIE CLABOTS made a loss of €61,504.
Where can I find the annual accounts of PHARMACIE CLABOTS?
PHARMACIE CLABOTS filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of PHARMACIE CLABOTS due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to PHARMACIE CLABOTS

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.